![Karen Smith](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karen Smith
Direttore/Membro del Consiglio presso EMYRIA LIMITED
Patrimonio netto: 205 077 $ in data 31/05/2024
Profilo
La dott.ssa Karen L. Smith è direttore medico di Emergent BioSolutions, Inc., amministratore indipendente di Antares Pharma, Inc., amministratore indipendente di Sangamo Therapeutics, Inc. e amministratore indipendente di Acceleron Pharma, Inc. Fa parte del consiglio di amministrazione di Antares Pharma, Inc., Sangamo Therapeutics, Inc. e Acceleron Pharma, Inc. La dott.ssa Smith è stata precedentemente impiegata come presidente e amministratore delegato di Medeor Therapeutics, Inc., amministratore delegato di Eliminate Cancer, Inc., amministratore e vicepresidente di Celator Pharmaceuticals, Inc, un amministratore non esecutivo di Forward Pharma A/S, un Chief Medical Officer & EVP-Research & Development di Jazz Pharmaceuticals Plc, un SVP-Global Medical Affairs & Head-Dermatology di Allergan, Inc., un Head-External Medical Relations di AstraZeneca LP, un Head-US Clinical Operations di Bristol Myers Squibb Co. e un Chief Executive Officer di Boron Molecular Ltd. È stata anche membro del consiglio di amministrazione di Sucampo Pharmaceuticals, Inc. Ha conseguito la laurea presso la Curtin University of Technology, una laurea presso l'Università di Salford, un MBA presso l'Università del New England (Australia), un dottorato presso l'Università di Warwick e un dottorato presso la University of Western Australia.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
31/03/2024 | 194 690 ( 0.45% ) | 161 593 $ | 31/05/2024 | |
04/06/2024 | 77 100 ( 0.04% ) | 43 484 $ | 31/05/2024 | |
30/04/2024 | 0 ( -.--% ) | - $ | 31/05/2024 | |
-.--% | 13/06/2023 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Karen Smith
Società | Posizione | Inizio |
---|---|---|
SANGAMO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 28/06/2018 |
EMYRIA LIMITED | Direttore/Membro del Consiglio | 29/11/2021 |
AURINIA PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | 18/08/2023 |
Capstan Therapeutics, Inc.
![]() Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company based in San Diego, CA. Capstan Therapeutics aims to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. The company's platform technology, TLNPs, is designed to deliver payloads and gene editing tools to reprogram specific cell types in vivo. This technology has the potential to generate transformative therapies for various disease areas, including autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. Capstan Therapeutics, Inc. was founded in 2022 by Haig Aghajanian. Laura K. Shawver has been the CEO of the company since 2022. | Direttore/Membro del Consiglio | - |
Novosteo, Inc.
![]() Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Direttore Tecnico/Scientifico/R&S | - |
Mariana Oncology, Inc.
![]() Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | Direttore/Membro del Consiglio | 08/03/2022 |
Precedenti posizioni note di Karen Smith
Società | Posizione | Fine |
---|---|---|
QUINCE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2023 |
ANTARES PHARMA, INC. | Direttore/Membro del Consiglio | 24/05/2022 |
ACCELERON PHARMA INC. | Direttore/Membro del Consiglio | 19/11/2021 |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Karen Smith
University of Warwick | Doctorate Degree |
The University of Western Australia | Doctorate Degree |
University of New England (Australia) | Masters Business Admin |
University of Salford | Graduate Degree |
Curtin University of Technology | Undergraduate Degree |
University of California, Los Angeles | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 7 |
---|---|
JAZZ PHARMACEUTICALS PLC | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
SANGAMO THERAPEUTICS, INC. | Health Technology |
EMERGENT BIOSOLUTIONS INC. | Health Technology |
EMYRIA LIMITED | Technology Services |
QUINCE THERAPEUTICS, INC. | Health Technology |
AURINIA PHARMACEUTICALS INC. | Health Technology |
Aziende private | 16 |
---|---|
Forward Pharma A/S
![]() Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Forward Pharma A/S is a biopharmaceutical company, which engages in the research and development of medicinal treatment for inflammatory and neurological indications. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 2005 and is headquartered in Copenhagen, Denmark. | Health Technology |
Celator Pharmaceuticals, Inc.
![]() Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Celator Pharmaceuticals, Inc. engages in the research and development of biopharmaceutical products. The company was founded by Lawrence David Mayer, and Marcel B. Bally in 1999 and is headquartered in Ewing, NJ. | Health Technology |
Allergan, Inc.
![]() Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Boron Molecular Ltd.
![]() Boron Molecular Ltd. Chemicals: Major DiversifiedProcess Industries Boron Molecular Ltd. manufactures fine chemicals. Its products include biaryls, boronic acid esters and acids, catalyst, cubanes, diborons, energy storage, halides, polymer, raft agents, and trifluoroborates. The company was founded in 2001 and is headquartered in Noble Park, Australia. | Process Industries |
Sucampo Pharmaceuticals, Inc.
![]() Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Acceleron Pharma, Inc.
![]() Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ. | Health Technology |
Antares Pharma, Inc.
![]() Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Medeor Therapeutics, Inc.
![]() Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Health Services |
Eliminate Cancer, Inc. | |
Humanetics Corp.
![]() Humanetics Corp. Pharmaceuticals: MajorHealth Technology Humanetics Corp. engages in development and commercialization of bioactive compounds. Its products include radiation modulators, mechanism of action, safety and toxicology, and pharmacokinetics. It focuses on oncology, medical imaging, and medical countermeasures. The company was founded by Ronald J. Zenk in 1988 and is headquartered in Edina, MN. | Health Technology |
Mariana Oncology, Inc.
![]() Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | Health Technology |
Jazz Pharmaceuticals, Inc.
![]() Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Talaris Therapeutics, Inc.
![]() Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company, which engages in the development of allogeneic hematopoietic stem cell transplantation. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Wellesley, MA. | Health Technology |
Novosteo, Inc.
![]() Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Health Technology |
AstraZeneca LP
![]() AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Capstan Therapeutics, Inc.
![]() Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company based in San Diego, CA. Capstan Therapeutics aims to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. The company's platform technology, TLNPs, is designed to deliver payloads and gene editing tools to reprogram specific cell types in vivo. This technology has the potential to generate transformative therapies for various disease areas, including autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. Capstan Therapeutics, Inc. was founded in 2022 by Haig Aghajanian. Laura K. Shawver has been the CEO of the company since 2022. | Commercial Services |
- Borsa valori
- Insiders
- Karen Smith